[Alendronate]
- PMID: 18830037
[Alendronate]
Abstract
Alendronate is one of a few pharmaceutical agents that have evidence to protect both vertebral and non-vertebral fracture. Here I review its effects on fracture prevention, as well as on surrogate markers such as bone mineral density, height loss, metabolic bone markers. Its effects on activities of daily living and quality of life will also be touched upon.
Similar articles
-
[Goals of treatment for osteoporosis].Clin Calcium. 2008 Oct;18(10):1389-95. Clin Calcium. 2008. PMID: 18830034 Review. Japanese.
-
[Evidence of alendronate treatment for osteoporosis].Nihon Rinsho. 2007 Nov 28;65 Suppl 9:337-43. Nihon Rinsho. 2007. PMID: 18161127 Review. Japanese. No abstract available.
-
[Drug therapy for prevention of falls and fractures].Med Klin (Munich). 2006 Jun;101 Suppl 1:1-5. doi: 10.1007/s00063-006-9001-y. Med Klin (Munich). 2006. PMID: 16826362 German.
-
[Parathyroid and bone. Evidence and perspective of parathyroid therapy for patients with osteoporosis].Clin Calcium. 2007 Dec;17(12):1888-94. Clin Calcium. 2007. PMID: 18057665 Review. Japanese.
-
[Increase in bone mineral density and its effect on fracture risk].Clin Calcium. 2005 Apr;15(4):625-9. Clin Calcium. 2005. PMID: 15802775 Review. Japanese.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical